Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.
Start Over | Back to Previous Screen
Lidocaine Hydrochloride (Xylocaine) Injection
Status: Currently in Shortage
»Date first posted:
02/22/2012
»Therapeutic Categories: Anesthesia; Pediatric
American Regent/Luitpold (Reverified 03/30/2021)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1%, 50 mL vial package of 25 (NDC 00517-0625-25) | Unavailable-No product available for release. No plan to manufacture. | Discontinuation of the manufacture of the drug |
Amphastar Pharmaceuticals, Inc./IMS (Reverified 08/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2%, 5mL Luer-Jet Prefilled Syringe (NDC 76329-3390-1)(old NDC 0548-3390-00) | Backordered due to the increase in demands | Demand increase for the drug |
Eugia Pharma Specialties LTD. (formerly Aurobindo) (Reverified 08/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 2% MDV 1000mg/50mL (NDC 55150-256-50) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 2 mL Ampoule (NDC 55150-158-72) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 5 mL Ampoule (NDC 55150-159-74) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 2% 2 mL Ampoule (NDC 55150-160-72) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 2 mL Single Dose Vial (NDC 55150-161-02) | Currently on backorder - next shipment anticipated Mid July | Demand increase for the drug | |
| 1% 5 mL Single Dose Vial (NDC 55150-162-05) | Currently on backorder - next shipment anticipated Late July | Demand increase for the drug | |
| 1% 30 mL Single Dose Vial (NDC 55150-163-30) | Currently on backorder - next shipment anticipated Late Aug | Demand increase for the drug | |
| 2% 2 mL Single Dose Vial (NDC 55150-164-02) | Currently on backorder - next shipment anticipated Late Aug | Demand increase for the drug | |
| 2% 5 mL Single Dose Vial (NDC 55150-165-05) | Currently on backorder - next shipment Mid July | Demand increase for the drug | |
| 1% 10 mL Multi Dose Vial (NDC 55150-251-10) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 1% 20 mL Multi Dose Vial (NDC 55150-252-20) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 2% 10 mL Multi Dose Vial (NDC 55150-254-10) | Currently on backorder - next shipment TBD | Demand increase for the drug | |
| 2% 20 mL Multi Dose Vial (NDC 55150-255-20) | Currently on backorder - next shipment anticipated Mid July | Demand increase for the drug |
Fresenius Kabi USA, LLC (Revised 08/12/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)discontinued | Not available at this time. | Demand increase for the drug | |
| Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued | Not available at this time. | Demand increase for the drug | |
| Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50)-NDC discontinued | Not available at this time. | Demand increase for the drug | |
| Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97) | Backordered. Next release date not available at this time. | Demand increase for the drug | |
| Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57) | Not available at this time. | Demand increase for the drug | |
| Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27) | Backordered. Next release September 2022. | Demand increase for the drug | |
| Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57) | Backordered. Next release September 2022. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80) | Not available at this time. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89) | Not available at this time. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57) | Backordered. Next release August 2022. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37) | Backordered. Next release September 2022. | Demand increase for the drug | |
| Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31) | Not available at this time. | Demand increase for the drug |
Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 01/13/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1% 5 mL vial, Preservative Free (NDC 0143-9595-25) | This presentation is temporarily on backorder. | Demand increase for the drug | |
| 2% 5 mL vial, Preservative Free (NDC 0143-9594-25) | Inventory is currently available. | Demand increase for the drug | |
| 1% 50 mL vial, Preserved (NDC 0143-9577-10) | This presentation is temporarily on backorder. | Demand increase for the drug | |
| 2% 50 mL vial, Preserved (NDC 0143-9575-10) | This presentation is temporarily on backorder. | Demand increase for the drug |
Hospira, Inc. (Revised 07/01/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 300 mg/20 mL (1.5%; 15 mg/mL); Glass Ampul (NDC 0409-4776-01) | Limited Supply Available. Next Delivery and Estimated Recovery: June 2022 | Demand increase for the drug | |
| 50 mg/5 mL (1%; 10 mg/mL); Ansyr Plastic Syringe (NDC 0409-9137-05) | Available | Other | |
| 20 mg/2 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-32) | Next Delivery: September 2022; Estimated Recovery: March 2023 | Demand increase for the drug | |
| 200 mg/20 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-01, pack of 25; NDC 0409-4276-16, individual) | Next Delivery: July 2022; Estimated Recovery: March 2023 | Demand increase for the drug | |
| 300 mg/30 mL (1%; 10 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4279-02) | Next Delivery: September 2022; Estimated Recovery: March 2023 | Demand increase for the drug | |
| 500 mg/50 mL (1%; 10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-02; NDC 0409-4276-17, individual) | Next Delivery and Estimated Recovery: August 2022 | Demand increase for the drug | |
| 40 mg/2 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-01) | Next Delivery and Estimated Recovery: July 2022 | Other | |
| 200 mg/10 mL (2%; 20 mg/mL); Glass Ampul (NDC 0409-4282-02) | Next Delivery and Estimated Recovery: July 2022 | Demand increase for the drug | |
| 50 mg/5 mL (1%; 10 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4904-34) | Next Delivery and Estimated Recovery: June 2022 | Demand increase for the drug | |
| 100 mg/5 mL (2%; 20 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4903-34) | Next Delivery: June 2022; Estimated Recovery: January 2023 | Other | |
| 100 mg/5 mL (2%; 20 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-2066-05) | Next Delivery: October 2022; Estimated Recovery: March 2023 | Demand increase for the drug | |
| 400 mg/20 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-01, pack of 25; NDC 0409-4277-16, individual) | Next Delivery: July 2022; Estimated Recovery: March 2023 | Demand increase for the drug | |
| 1,000 mg/50 mL (2%; 20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-02) | Next Delivery: June 2023; Estimated Recovery: December 2023 | Demand increase for the drug | |
| 200 mg/5 mL (4%; 40 mg/mL); Glass Ampul (NDC 0409-4283-01) | Limited Supply Available. Next Delivery: July 2022; Estimated Recovery: August 2022 | Demand increase for the drug | |
| Xylocaine Cardiac 100 mg/5 mL (2%; 20 mg/mL); Ansyr Plastic Syringe (NDC 0409-1323-05) | Next Delivery: June 2022; Estimated Recovery: January 2023 | Other | |
| 250 mg/50 mL (0.5%; 5 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4275-01) | Next Delivery: April 2023; Estimated Recovery: June 2023 | Other | |
| 100 mg/2 mL (5%; 50 mg/mL) and 7.5% Dextrose; Glass Ampul (NDC 0409-4712-01) | Discontinued | Discontinuation of the manufacture of the drug | |
| 250 mg/50 mL (0.5%; 5 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4278-01) | Next Delivery and Estimated Recovery: June 2022 | Demand increase for the drug | |
| 50 mg/5 mL (1%; 10 mg/mL); Glass Ampul (NDC 0409-4713-02) | Next Delivery: July 2022; Estimated Recovery: August 2022 | Demand increase for the drug |
Spectra Medical Devices, Inc. (Revised 01/07/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| 1% 5 mL ampule (NDC 65282-1605-1) | Available | Other |